Adiponectin and Cardiovascular Outcomes among Hemodialysis Patients | Zendy

Emad Abdallah | Zendy; Emam Waked | Zendy; Malak Nabil | Zendy; Omnia El-Bendary | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Adiponectin and Cardiovascular Outcomes among Hemodialysis Patients

Author(s) -

Emad Abdallah,

Emam Waked,

Malak Nabil,

Omnia El-Bendary

Publication year - 2012

Publication title -

kidney and blood pressure research

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.806

H-Index - 51

eISSN - 1423-0143

pISSN - 1420-4096

DOI - 10.1159/000334649

Subject(s) - medicine , adiponectin , hemodialysis , population , kidney disease , nephrology , confidence interval , endocrinology , obesity , insulin resistance , environmental health

Adiponectin (ADPN) levels are consistently elevated among patients with advanced chronic kidney disease, but its relationship with cardiovascular outcomes in this population remains controversial. The aim of our study was to measure the plasma levels of ADPN in patients with end-stage renal disease on maintenance hemodialysis (HD) and we studied its correlates to cardiovascular outcomes and mortality.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research